We're upgrading our payment system — orders are currently handled via WhatsAppMessage us →
20% offAll GLP-1s
Mito LabsMito Labs.
All Products
Retatrutide (RT3-GLP) 10mg
Weight Management

Retatrutide (RT3-GLP) 10mg

Triple receptor agonist studied in clinical research on GLP-1, GIP, and glucagon pathway modulation.

Rp 3.100.000$187.00

In Stock

SKU: ML-RETA-10MG

1

💰 Volume Discounts:

Buy 3+ vials = 10% off · Buy 5+ vials = 15% off

Retatrutide is an investigational triple receptor agonist that activates GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously. Published Phase II clinical research (New England Journal of Medicine, 2023) has investigated its effects on body weight, metabolic markers, and adipose tissue in controlled trial populations. Retatrutide is currently in clinical development and is not approved as a medication by the FDA or other regulatory bodies. For in-vitro and laboratory research use only.